Product Description: CGP52608 is a selective agonist for the RZR/ROR receptor, known for its anti-tumor activity, and has almost no affinity for the cell surface G-protein coupled melatonin receptor. CGP52608 can inhibit the growth of mouse 16/C breast cancer cells. CGP52608 can induce the formation of vesicles in diatoms[1][2].
Formula: C8H12N4OS2
References: [1]S T Tslm, et al. CGP 52608-induced cyst formation in dinoflagellates: possible involvement of a nuclear receptor for melatonin. J Pineal Res. 1996 Sep;21(2):101-7./[2]Katarzyna Winczyk, et al. Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells. Neuro Endocrinol Lett. 2006 Jun;27(3):351-4.
CAS Number: 87958-67-6
Molecular Weight: 244.34
Research Area: Cancer
Target: Melatonin Receptor